معرفی
Zoe McQuilten is a Professor (Research) at Monash University's School of Public Health and Preventive Medicine. Her work focuses on hematology, critical care, and clinical trial design, with particular expertise in blood transfusion practices and oncology-related outcomes. She leads major research projects such as the 'Making better use of blood' initiative and the 'Antithrombotic therapy to ameliorate clinical complications in community acquired pneumonia (ATTACC-CAP)' study. She has received prestigious awards including the NHMRC Synergy Grant in 2019 for national transfusion research. Her research spans over 190 publications and 75+ projects, emphasizing translational research in hematology and critical care medicine.
- Education: Not explicitly listed in the provided text.
- Key Projects: Includes multi-institutional collaborations on blood stewardship, anticoagulant therapies, and myeloma treatment outcomes.
Her research interests include optimizing transfusion practices, improving outcomes for blood transfusion patients, and addressing challenges in managing hematological malignancies. She has contributed to adaptive platform trials and registry-based studies, such as the Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR).
Her scientific awards include the 2019 NHMRC Synergy Grant for addressing national blood transfusion priorities. She has secured significant grant funding, such as the Abbvie MRDR Support project (2024–2025) and leadership in large-scale clinical trials like the Threshold for Platelets study.
Her work frequently involves collaboration across disciplines, including infectious disease management, critical care innovation, and oncology biomarker research. She has pioneered studies on genetic markers (e.g., 1q21 amplification in myeloma) and economic analyses of hematological disorders.
